Abstract
Identification of high-risk patients for sudden cardiac death (SCD) remains difficult. Non-invasive markers evaluating changes in heart rate and ventricular repolarisation (VR) have been developed to stratify this risk. Most studies using VR analysis rely on static analysis of the QT interval which is poorly reproducible and heart rate dependent. Dynamic VR analysis assesses QT interval modification according to RR duration of the precedent heart cycle. This relation is characterized by the linear regression QT/RR (y = ax+b) thus defined by its slope (a) and the value of the QT for a virtual null RR cycle (b). Analysis can be made for QTa (apex) and QTe (end). In healthy subjects, the difference of QT/RR slopes observed between day and night highly suggest that the QT/RR slope is influenced by the autonomic tone. The QT/RR slope is also influenced by clinical, physiological, pharmacological and various diseases associated with an increased risk of SCD. The prognostic value of the QT/RR slope for SCD has been demonstrated after myocardial infarction and in chronic heart failure. These results suggest that QT dynamicity is a promising tool able to identify patients at risk of SCD.
Keywords: QT/RR, QT dynamicity, ventricular repolarization, sudden cardiac death, Autonomic system, Ventricular arrhythmias
Current Cardiology Reviews
Title: Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Volume: 2 Issue: 4
Author(s): Olivier Xhaet, Philippe van de Borne and Atul Pathak
Affiliation:
Keywords: QT/RR, QT dynamicity, ventricular repolarization, sudden cardiac death, Autonomic system, Ventricular arrhythmias
Abstract: Identification of high-risk patients for sudden cardiac death (SCD) remains difficult. Non-invasive markers evaluating changes in heart rate and ventricular repolarisation (VR) have been developed to stratify this risk. Most studies using VR analysis rely on static analysis of the QT interval which is poorly reproducible and heart rate dependent. Dynamic VR analysis assesses QT interval modification according to RR duration of the precedent heart cycle. This relation is characterized by the linear regression QT/RR (y = ax+b) thus defined by its slope (a) and the value of the QT for a virtual null RR cycle (b). Analysis can be made for QTa (apex) and QTe (end). In healthy subjects, the difference of QT/RR slopes observed between day and night highly suggest that the QT/RR slope is influenced by the autonomic tone. The QT/RR slope is also influenced by clinical, physiological, pharmacological and various diseases associated with an increased risk of SCD. The prognostic value of the QT/RR slope for SCD has been demonstrated after myocardial infarction and in chronic heart failure. These results suggest that QT dynamicity is a promising tool able to identify patients at risk of SCD.
Export Options
About this article
Cite this article as:
Xhaet Olivier, van de Borne Philippe and Pathak Atul, Dynamic Ventricular Repolarisation: From Physiology to Prognosis, Current Cardiology Reviews 2006; 2 (4) . https://dx.doi.org/10.2174/157340306778772931
DOI https://dx.doi.org/10.2174/157340306778772931 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Steroidal Conjugates and Their Pharmacological Applications
Current Medicinal Chemistry Isolation and Proteomic Characterization of Bacterial Extracellular Membrane Vesicles
Current Protein & Peptide Science Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics
Current Cardiology Reviews Rheumatoid Arthritis: An Evolutionary Force in Biologics
Current Pharmaceutical Design Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Zuogui Yin in the Treatment of Male Infertility
Combinatorial Chemistry & High Throughput Screening Antiangiogenic Therapeutic Approaches in Multiple Myeloma
Current Cancer Drug Targets Design, Synthesis, and Bioactivity of Pyrazole Acid Derivatives as Endothelin Receptor Antagonists
Medicinal Chemistry Recent Patents on Rho Signaling Pathway as Therapeutic Target for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Identification and Determination of Potential Impurities Present in the Acyclovir Drug Substance by GC-MS
Current Pharmaceutical Analysis Stem Cell Based Tissue Engineering and Regenerative Medicine: A Review Focusing on Adult Stem Cells
Current Tissue Engineering (Discontinued) Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Current Medicinal Chemistry Synthesis and Biological Activity of N-(arylsulfonyl) Valine Hydrazones and Assistance of NMR Spectroscopy for Definitive 3D Structure
Letters in Drug Design & Discovery Increased Risk of Dementia in Patients with Non-Apnea Sleep Disorder
Current Alzheimer Research Physical Activity and Hypertension: Evidence of Cross-Sectional Studies,Cohort Studies and Meta-Analysis
Current Hypertension Reviews Redox Homeostasis and Epigenetics in Non-alcoholic Fatty Liver Disease (NAFLD)
Current Pharmaceutical Design Platelet Activation, Inflammatory Mediators and Hypercholesterolemia
Current Vascular Pharmacology Biomarkers of Oxidative Stress and Cataract. Novel Drug Delivery Therapeutic Strategies Targeting Telomere Reduction and the Expression of Telomerase Activity in the Lens Epithelial Cells with N-Acetylcarnosine Lubricant Eye Drops: Anti-Cataract which Helps to Prevent and Treat Cataracts in the Eyes of Dogs and other Animals
Current Drug Delivery Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification
Recent Patents on Anti-Cancer Drug Discovery INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies
Current Bioactive Compounds